ReviewMedscape journal of medicine2008
Diabetes care - insulin delivery in a changing world.
Review in Medscape journal of medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Impact of Injection Speed, Volume, and Site on Pain Sensation.Journal of diabetes science and technology · 2018Trial
- Trial
- Advantages and disadvantages of connected insulin pens in diabetes management.Endocrine connections · 2023Review
- Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review.Journal of diabetes science and technology · 2023Review
- Insulin pumps in children - a systematic review.World journal of clinical pediatrics · 2022Article
- Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary.Journal of diabetes science and technology · 2022Article
- The Review of Insulin Pens-Past, Present, and Look to the Future.Frontiers in endocrinology · 2022Review
- Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection.Journal of diabetes science and technology · 2019Article
- Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.Journal of diabetes science and technology · 2015Article
- Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes.Journal of diabetes science and technology · 2014Article
- Evolution of diabetes insulin delivery devices.Journal of diabetes science and technology · 2010Review
- Practical aspects of insulin pen devices.Journal of diabetes science and technology · 2010Review
- Insulin delivery methods: Past, present and future.International journal of pharmaceutical investigationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Controlling blood glucose levels within acceptable limits is crucial to the long-term health of patients with type 2 diabetes, and patient involvement is a vital element in achieving this goal. The benefits of patient education and chronic disease management tools cannot be underestimated as many patients will require initiation of insulin therapy to achieve glycemic targets. The wide choice of insulin formulations and the ever-expanding range of delivery methods now available make insulin administration easier, less painful, more discreet, and more accurate than ever before, thus providing important tools to overcome barriers to insulin initiation and improve achievement of glycemic goals. In addition, exciting developments in technology for self-monitoring of blood glucose have increased the potential for optimal glycemic control. This review discusses how these approaches can help patients manage their diabetes.
Indexed as
Identifiers
18596953PMC2438492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.